NASDAQ:BCPCBalchem Stock Price, Forecast & News

Balchem's stock was trading at $89.29 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BCPC shares have increased by 15.1% and is now trading at $102.76.
View which stocks have been most impacted by COVID-19.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Balchem.

Balchem is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Balchem.

Balchem Co. (NASDAQ:BCPC) announced its quarterly earnings data on Friday, July, 31st. The basic materials company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.55 by $0.30. The basic materials company earned $173.36 million during the quarter, compared to analysts' expectations of $161.35 million. Balchem had a net margin of 12.18% and a return on equity of 14.32%. The business's quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter last year, the company earned $0.77 EPS.
View Balchem's earnings history.

Balchem declared an annual dividend on Wednesday, December 18th. Stockholders of record on Monday, December 30th will be paid a dividend of $0.52 per share on Friday, January 17th. This represents a dividend yield of 0.51%. The ex-dividend date is Friday, December 27th. This is a positive change from Balchem's previous annual dividend of $0.47.
View Balchem's dividend history.

2 equities research analysts have issued 12-month price targets for Balchem's stock. Their forecasts range from $100.00 to $126.00. On average, they anticipate Balchem's share price to reach $113.00 in the next twelve months. This suggests a possible upside of 10.0% from the stock's current price.
View analysts' price targets for Balchem.

Media headlines about BCPC stock have trended negative this week, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Balchem earned a media sentiment score of -2.4 on InfoTrie's scale. They also gave press coverage about the basic materials company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future.
View the latest news about Balchem.

Balchem saw a decline in short interest in the month of July. As of July 31st, there was short interest totaling 433,300 shares, a decline of 12.4% from the July 15th total of 494,500 shares. Based on an average daily volume of 167,300 shares, the short-interest ratio is presently 2.6 days. Currently, 1.4% of the company's stock are short sold.
View Balchem's Short Interest.

Some companies that are related to Balchem include Sherwin-Williams (SHW), Ecolab (ECL), International Flavors & Fragrances (IFF), Celanese (CE), RPM International (RPM), Albemarle (ALB), Ashland Global (ASH), NewMarket (NEU), Quaker Chemical (KWR), W. R. Grace & Co (GRA), Stepan (SCL), HB Fuller (FUL), PolyOne (POL), Sensient Technologies (SXT) and Innospec (IOSP).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Ecolab (ECL), AbbVie (ABBV), CVS Health (CVS), IBM (IBM), Lowe's Companies (LOW), AT&T (T), Enterprise Products Partners (EPD), Mcdonald's (MCD), Altria Group (MO) and Merck & Co., Inc. (MRK).

Balchem trades on the NASDAQ under the ticker symbol "BCPC."

Balchem's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Conestoga Capital Advisors LLC (2.75%), Wasatch Advisors Inc. (2.58%), Macquarie Group Ltd. (1.79%), FMR LLC (1.26%), Bank of New York Mellon Corp (1.16%) and GW&K Investment Management LLC (1.12%). Company insiders that own Balchem stock include Daniel E Knutson, David F Ludwig and Scott C Mason.
View institutional ownership trends for Balchem.

BCPC stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., New York State Common Retirement Fund, ProShare Advisors LLC, Moody Aldrich Partners LLC, Prudential Financial Inc., Principal Financial Group Inc., State of Tennessee Treasury Department, and PNC Financial Services Group Inc..
View insider buying and selling activity for Balchem.

BCPC stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Assenagon Asset Management S.A., Bank of Montreal Can, State of Wisconsin Investment Board, Conestoga Capital Advisors LLC, Macquarie Group Ltd., GW&K Investment Management LLC, and First Trust Advisors LP. Company insiders that have bought Balchem stock in the last two years include Daniel E Knutson, and Scott C Mason.
View insider buying and selling activity for Balchem.

Shares of BCPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BCPC stock can currently be purchased for approximately $102.76.

Balchem has a market capitalization of $3.32 billion and generates $643.71 million in revenue each year. The basic materials company earns $79.67 million in net income (profit) each year or $3.19 on an earnings per share basis. Balchem employs 1,424 workers across the globe.

The official website for Balchem is www.balchem.com.

Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The basic materials company can be reached via phone at 845-326-5600 or via email at [email protected]